Straive Named a Leader in Life Sciences and Healthcare AI Services
Recognition reflects Straive’s ability to combine advanced AI capabilities with scientific, clinical, and regulatory expertise across regulated life sciences and healthcare workflows.
New York, 3rd August, 2026 — Straive has been named a Leader in AIM Research’s Top AI Service Providers for Life Sciences and Healthcare 2026 Penetration Maturity (PeMa) Quadrant.
The annual initiative recognizes leading AI service providers in life sciences and healthcare, establishes an industry benchmark, and helps technology buyers assess vendor potential.
The recognition reflects Straive’s capabilities across clinical development, regulatory affairs, pharmacovigilance, scientific knowledge management, medical content automation, healthcare data engineering, commercial intelligence, and post-market surveillance.
Recognition Overview
Life Sciences and Healthcare AI Coverage
Straive applies AI across the life sciences and healthcare value chain, spanning clinical development, regulatory affairs, pharmacovigilance, scientific knowledge management, medical content automation, healthcare data engineering, commercial intelligence, and post-market surveillance.
Purpose-Built AI Assets
Proprietary accelerators such as Hypoforge, ClinicalGen, Patient Pulse, TrialIntel, and the Adverse Events Tool address specific research, clinical, regulatory, and safety workflows.
Domain-Grounded Delivery
Scientific, clinical, and regulatory expertise is combined with cloud-native AI platforms, reusable accelerators, and human expert validation to develop solutions for regulated environments.
Enterprise AI Readiness
Straive combines Data & AI delivery, AI workflow orchestration, industry-specific accelerators, responsible AI frameworks, and cloud and data partnerships to move AI into scalable, production-ready operations.
Why We Stood Out?
1,000+
life sciences professionals, including 600+ domain experts and 38+ PhDs.
400+
AI/ML engineers, data architects, and MLOps specialists.
45+
AI engagements, 30+ production deployments, and an 80% POC-to-production conversion rate.
Executive Perspective
“ Being recognized as a Leader reflects our focus on combining advanced AI engineering with deep scientific, clinical, and regulatory expertise. We are committed to helping life sciences and healthcare organizations move AI beyond experimentation and into trusted, scalable, and production-ready workflows. ”
Namit Sureka
President & Chief Analytics & AI Officer, Straive
AIM Research (Data & AI) Analyst Perspective
“Straive’s differentiation lies in its “build AI and run AI” operating model, where AI deployment is coupled with workflow redesign and continuous operationalization. By embedding scientific and regulatory experts within delivery teams and leveraging ontology-driven intelligence, the firm brings domain context into AI implementation across clinical development, regulatory affairs, pharmacovigilance, quality, and commercial operations. For technology buyers, this execution model helps translate AI from proof of concept into production-ready capabilities that integrate seamlessly into regulated pharmaceutical workflows.”
Analyst Perspective
“Straive’s differentiation lies in its “build AI and run AI” operating model, where AI deployment is coupled with workflow redesign and continuous operationalization. By embedding scientific and regulatory experts within delivery teams and leveraging ontology-driven intelligence, the firm brings domain context into AI implementation across clinical development, regulatory affairs, pharmacovigilance, quality, and commercial operations. For technology buyers, this execution model helps translate AI from proof of concept into production-ready capabilities that integrate seamlessly into regulated pharmaceutical workflows.”
Yashashree Vivarekar
Research Analyst – Data and AI, AIM Research
About Straive
Straive operationalizes Data Analytics and AI for global enterprises, including several Fortune 500 companies. The company develops advanced data analytics and AI solutions and integrates them into clients’ core workflows to improve efficiency, strengthen user experiences, and support revenue growth.
Straive serves organizations across Pharmaceutical and Life Sciences, Banking and Financial Services, Global Capability Centers, Retail and CPG, Media, Sports and Entertainment, Energy, EdTech, Science and Research, Manufacturing and Supply Chain, and Education. Its strategically positioned resource pool operates across the Philippines, India, the United States, Nicaragua, Vietnam, the United Kingdom, Singapore, South Africa, the UAE, and Canada.
About AIM Research
AIM Research is an AI and data science market research firm specializing in insights into modern data, analytics, and artificial intelligence markets. Its research and advisory initiatives, including the PeMa Quadrants, are designed to help enterprise buyers evaluate technology and service providers.